Delirium: prevention, diagnosis and management in hospital and long-term care

Equality impact assessment Final (PDF 158 KB)

Committee member list (PDF 126 KB)

Draft guidance consultation

Draft guideline (PDF 192 KB)

Evidence review A (PDF 2.58 MB)

Committee meeting

Minutes 1 (PDF 162 KB)

Stakeholder list updated

Stakeholder list (PDF 119 KB)

Surveillance consultation

Surveillance consultation

Surveillance review proposal (PDF 1.01 MB)

Comments form (MSWord 28 KB)

Review documents

Surveillance review proposal information

Stakeholder list - review proposal (PDF 191 KB)

Review proposal (PDF 471 KB)

Surveillance review decision (PDF 699 KB)

Other information

Evidence update (PDF 350 KB)

Background information

New NICE guideline set to encourage healthcare professionals to 'think delirium' and take steps to prevent it information

2010/103 New NICE guideline set to encourage healthcare professionals to 'think delirium' and take steps to prevent it (PDF 166 KB)

Remit

Remit (PDF 14 KB)

Stakeholder list and how to register

List of stakeholders (PDF 23 KB)

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope

Final scope (PDF 111 KB)

Stakeholder comments on draft scope (PDF 199 KB)

Scope consultation information

Draft scope for consultation (PDF 119 KB)

Draft scope comments proforma (MSWord 48 KB)

List of stakeholders (PDF 23 KB)

Guideline development and consultation

Guideline development and consultation

Equalities impact assessment (recommendations) (PDF 29 KB)

GDG membership list (PDF 19 KB)

Minutes for GDG meetings

Delirium GDG minutes: 16 July 2009 (PDF 35 KB)

Delirium GDG minutes: 15 July 2009 (PDF 35 KB)

Delirium GDG minutes: 22 April 2009 (PDF 34 KB)

Delirium GDG minutes: 3-4 July 2008 (PDF 38 KB)

Delirium GDG minutes: 13 November 2008 (PDF 19 KB)

Delirium GDG minutes: 21-22 January 2009 (PDF 20 KB)

Delirium GDG minutes: 4 March 2009 (PDF 87 KB)

Draft guideline consultation information

Draft full guideline for consultation (PDF 1.85 MB)

Algorithm (PDF 45 KB)

Appendices

Appendices and contents page (PDF 615 KB)

Appendix D adverse effects - included studies (PDF 233 KB)

Appendix D consequences of - included studies (PDF 155 KB)

Appendix D diagnostic test accuracy - included studies (PDF 182 KB)

Appendix D epidemiology - included studies (PDF 214 KB)

Appendix D non pharmacological risk factors - included studies (PDF 90 KB)

Appendix D pharmacological risk factors - included studies (PDF 49 KB)

Appendix E consequences of cohort studies - methodological quality (PDF 125 KB)

Appendix E diagnostic accuracy tests - methodological quality (PDF 172 KB)

Appendix E epidemiology - methodological quality (PDF 168 KB)

Appendix E non-pharmacological risk factors cohort studies - methodological quality (PDF 44 KB)

Appendix E pharmacological risk factors cohort studies - methodological quality (PDF 29 KB)

Appendix E patient information - methodological quality (PDF 213 KB)

Appendix F consequences of - multivariate risk factors (PDF 185 KB)

Appendix F - non-pharmacological risk factors - multivariate risk factors (PDF 293 KB)

Appendix F pharmacological risk factors - multivariate risk factors (PDF 63 KB)

Appendix G diagnostic test accuracy - excluded studies (PDF 128 KB)

Appendix G adverse effects review - excluded studies (PDF 121 KB)

Appendix G consequences of - excluded studies (PDF 55 KB)

Appendix G epidemiology review - excluded studies (PDF 146 KB)

Appendix G non-pharmacological risk factors - excluded studies (PDF 71 KB)

Appendix G information for patients review - excluded studies (PDF 118 KB)

Appendix G pharmacological risk factors - excluded studies (PDF 55 KB)

Appendix G references to excluded studies (PDF 151 KB)

Appendix K evidence summary - prevention (PDF 34 KB)

Appendix K evidence summary - treatment (PDF 39 KB)

Draft NICE guideline for consultation (PDF 250 KB)

Consultation table and with developers responses (PDF 1.02 MB)

List or registered stakeholders information

Published clinical guidelines information

clinical guidelines in development information

Clinical guidelines in development information

Pre-publication check

Pre-publication check information

Pre-publication check - stakeholder comments/developer responses (PDF 49 KB)

Full guideline (PDF 3.5 MB)

Full guideline appendices

Appendix A - Scope (PDF 64 KB)

Appendix B - Declaration of Interests (PDF 49 KB)

Appendix C - Search Strategies (PDF 174 KB)

Appendix D - Adverse Effects - Included studies (PDF 121 KB)

Appendix D - Consequences of - Included studies (PDF 155 KB)

Appendix D - Diagnostic Test Accuracy - Included Studies (PDF 182 KB)

Appendix D - Epidemiology - Included studies (PDF 91 KB)

Appendix D - Non pharmacological Risk factor - Included studies (PDF 44 KB)

Appendix D - Pharma Nonpharma Prevention Treatment - Included studies (PDF 170 KB)

Appendix D - Pharmacological Risk factors - Included studies (PDF 49 KB)

Appendix E - Consequences of (PDF 125 KB)

Appendix E - Diagnostic Accuracy Tests Methodological Quality (PDF 172 KB)

Appendix E - Epidemiology quality (PDF 71 KB)

Appendix E - Non Pharmacological Risk Factors (PDF 44 KB)

Appendix E - Patient info quality (PDF 80 KB)

Appendix E - Pharma NonPharma Prevention Treatment (PDF 107 KB)

Appendix E - Pharmacological Risk Factors review - Randomised controlled trials (PDF 23 KB)

Appendix E - Pharmacological Risk Factors review - cohort studies (PDF 30 KB)

Appendix G - References for Excluded Studies (PDF 93 KB)

Appendix H - Recommendations for Future Research (PDF 75 KB)

Appendix I - DSM-IV and Scales For Measuring (PDF 64 KB)

Appendix J - Health Economics (PDF 155 KB)

Appendix K - Forest Plots (PDF 462 KB)

Full guideline appendices

Consultation table and with developers responses (PDF 1.02 MB)

National Clinical Guideline Centre for Acute and Chronic Conditions